Basaglar Kwikpen
Generic: Insulin Glargine
InsulinAlso: BASAGLAR Tempo Pen✓ FDA-verified
View full FDA label ↗Basaglar Kwikpen is a long-acting insulin used to help manage blood sugar levels in adults and children with type 1 diabetes and in adults with type 2 diabetes. It works by helping your body use sugar more effectively and reducing the amount of sugar produced by the liver. You take it as an injection under the skin, usually once a day at the same time, starting with a dose of about 0.2 units per kilogram of body weight or up to 10 units, and it can go up to a maximum of 80 units. It's important to know that you should not use Basaglar during low blood sugar episodes. Additionally, if you are switching from another long-acting insulin, you may need to adjust your dose accordingly.
✦
Uses
- Type 1 diabetes in adults and children.
- Type 2 diabetes in adults.
◷
Dosage
Inject BASAGLAR once daily at the same time each day.
Adjust dosage based on blood glucose levels and individual needs.
In type 1 diabetes, use with short-acting insulin.
Rotate injection sites to avoid skin problems.
Always follow your doctor's specific instructions for your dose.
⚠
Side effects
Common
hypoglycemiainjection site reactionsweight gain
Serious
allergic reactionssevere allergic reactionslipodystrophyhypokalemia
🛑
Warnings
⚠ Important warnings
- Not for treating diabetic ketoacidosis.
- Monitor blood glucose closely when starting BASAGLAR.
- Do not mix with other insulins or solutions.
- Use caution if you have vision problems.
⇄
Drug interactions
- Antidiabetic agentsmay increase risk of hypoglycemiaCaution
- Corticosteroidsmay decrease blood glucose lowering effectCaution
- Alcoholmay affect blood glucose levelsCaution
- Beta-blockersmay blunt signs of hypoglycemia.Caution
Ask about this drug
Answers pulled from the FDA label only.
Other Brands:
Medical Disclaimer: This content is provided for informational and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before taking any medication.
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).
MedDataTool